Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?

Nature Clinical Practice Gastroenterology & Hepatology volume 5, pages 414–415 (2008)Cite this article

boxed-textCunningham D et al. (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36–46

The substitution of capecitabine for fluorouracil and oxaliplatin for cisplatin should be recommended for patients with gastroesophageal cancer when it is feasible and appropriate

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Parkin DM et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108

    Article  Google Scholar 

  2. Pohl H and Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97: 142–146

    Article  Google Scholar 

  3. Narahara H et al. (2007) Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer. 2007 ASCO Annual Meeting Proceedings; J Clin Oncol 25 (Suppl 18): 4514

    Google Scholar 

  4. Wagner AD et al. (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24: 2903–2909

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jim Casey, Editorial Assistant, Nature Clinical Practice.

Author information

Author notes

  1. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Mail stop 426, Houston, Texas 77030, USA jajani@mdanderson.org

Authors and Affiliations

  1. JA Ajani is a Professor of Medicine at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Jaffer A Ajani

Authors
  1. Jaffer A Ajani
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ajani, J. Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?. Nat Rev Gastroenterol Hepatol 5, 414–415 (2008). https://doi.org/10.1038/ncpgasthep1177

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep1177

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing